Feld Michael, EVP and Chief Revenue Officer at Becton Dickinson & Co. ($BDX), sold shares on the open market seven times over the past year, totaling about $90,000. His most recent sale occurred on February 26, 2026. These sales rank him 9,730th among 11,678 insiders in our database by total value sold, well below the average of 8.6 million per insider across 6.4 transactions on average. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP, Chief Revenue Officer | S | Common Stock | 75 | $156.83 | 21,233.0000 | 285,845,000 | 0.35% | 0.00% |
| Feb. 26, 2026 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP, Chief Revenue Officer | S | Common Stock | 75 | $181.84 | 21,308.0000 | 285,845,000 | 0.35% | 0.00% |
| Jan. 26, 2026 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP, CRO & Pres. Life Sciences | S | Common Stock | 75 | $202.73 | 16,431.0000 | 285,845,000 | 0.45% | 0.00% |
| Dec. 26, 2025 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP, CRO & Pres. Life Sciences | S | Common Stock | 74 | $196.08 | 16,506.0000 | 288,509,000 | 0.45% | 0.00% |
| Dec. 1, 2025 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP, CRO & Pres. Life Sciences | S | Common Stock | 75 | $193.36 | 16,580.0000 | 288,509,000 | 0.45% | 0.00% |
| Nov. 26, 2025 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP, CRO & Pres. Life Sciences | A | Common Stock | 8829 | $0.00 | 17,074.0000 | 288,509,000 | 107.08% | 0.00% |
| Nov. 26, 2025 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP, CRO & Pres. Life Sciences | F | Common Stock | 419 | $0.00 | 16,655.0000 | 288,509,000 | 2.45% | 0.00% |
| Oct. 27, 2025 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP & President, Life Sciences | S | Common Stock | 57 | $186.01 | 8,245.0000 | 288,509,000 | 0.69% | 0.00% |
| Sept. 26, 2025 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP & President, Life Sciences | S | Common Stock | 58 | $181.03 | 8,302.0000 | 288,693,000 | 0.69% | 0.00% |
| Aug. 22, 2025 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP & President, Life Sciences | S | Common Stock | 57 | $197.99 | 8,360.0000 | 288,693,000 | 0.68% | 0.00% |
| Aug. 20, 2025 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP & President, Life Sciences | F | Common Stock | 773 | $0.00 | 8,417.0000 | 288,693,000 | 8.41% | 0.00% |
| Nov. 26, 2024 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP & President, Life Sciences | A | Common Stock | 2553 | $0.00 | 9,190.0000 | 291,009,000 | 38.47% | 0.00% |
| Nov. 26, 2024 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP & President, Life Sciences | A | Stock Appreciated Rights | 10004 | $0.00 | 10,004.0000 | 291,009,000 | 9999.99% | 0.00% |
| Aug. 20, 2024 | BECTON DICKINSON & CO | $BDX | Feld Michael | EVP & President, Life Sciences | A | Common Stock | 6637 | $0.00 | 6,637.0000 | 290,857,000 | 9999.99% | 0.00% |